GSK1322322

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, BacterialSkin Infections, Bacterial

Phase 1

Relative Bioavailability Study in Healthy Subjects

CompletedNCT00924911

GlaxoSmithKlineInfections, Bacterial

Start: 2009-04-27End: 2009-07-09Updated: 2017-06-26

A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

WithdrawnNCT01953809

GlaxoSmithKlineInfections, Bacterial

Start: 2014-08-31End: 2015-03-31Updated: 2015-01-28

Phase 2

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

CompletedNCT01209078

GlaxoSmithKlineSkin Infections, Bacterial

Start: 2010-08-17End: 2011-01-18Updated: 2017-12-04

Related Papers

Safety, Tolerability, and Efficacy of GSK1322322 in the Treatment of Acute Bacterial Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy2014-08-1940 citations